People with inflammatory bowel disease often have a more permeable intestinal barrier, and this same condition is commonly observed in other chronic diseases.
Mechanism
Synthesis from 5 studies
When the gut's protective mucus layer breaks down and the cells sealing the gut wall start to die, harmful bacterial products leak into the body and trigger inflammation. This inflammation makes the seal even weaker, creating a cycle that keeps the gut leaky and causes long-term health problems.
Most probable mechanism
A damaged gut lining becomes too porous because the protective mucus layer disappears, the cells that seal the gut wall break apart, and harmful bacterial products leak into the body, triggering inflammation that further weakens the barrier.
Defective processing of mucin proteins leads to depletion of mucus-producing cells and loss of the protective mucus layer lining the intestine.
Epithelial cells experience unresolved endoplasmic reticulum stress, which triggers their death and further reduces barrier integrity.
Epigenetic dysregulation increases the activity of enzymes that break down proteins holding intestinal cells together, causing tight junctions to disassemble.
Bacterial components such as lipopolysaccharides cross the compromised barrier and enter the bloodstream, activating immune receptors on immune cells.
Immune activation by bacterial products triggers low-grade inflammation that further damages tight junctions and suppresses mucus production.
Less supported by current evidence, but not ruled out
Certain gut bacteria produce chemicals that directly weaken the gut seal and irritate nerves, causing pain and altered movement without major inflammation.
Hydrogen sulfide produced by specific bacteria directly disrupts tight junctions between intestinal cells.
Hydrogen sulfide activates pain-sensing nerves in the gut wall, increasing sensitivity to normal gut activity.
Methane produced by archaea slows gut movement, leading to bacterial overgrowth and prolonged exposure to barrier-disrupting substances.
After a gut infection, the immune system mistakenly attacks cells that control gut movement, causing slow transit and bacterial buildup that worsens leakiness.
Antibodies made against a bacterial toxin cross-react with a structural protein in gut nerve and muscle cells.
This autoimmune attack damages the cells that coordinate rhythmic gut contractions.
Loss of coordinated movement causes food and bacteria to stagnate, promoting overgrowth and prolonged barrier stress.
When beneficial gut bacteria decline, they stop producing chemicals that help the gut lining stay intact and calm the immune system.
Reduction in fiber-fermenting bacteria lowers production of short-chain fatty acids that nourish intestinal cells and strengthen tight junctions.
Lower short-chain fatty acids reduce activation of anti-inflammatory pathways and weaken the gut's ability to repair itself.
Reduced bile acid modification diminishes signaling that normally suppresses inflammation and maintains barrier function.
Evidence from Studies
Supporting (5)
Community contributions welcome
Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission.
Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease
Phytic acid (InsP6) activates HDAC3 epigenetic axis to maintain intestinal barrier function
Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.